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Abstract 31 
Background: Diagnostic outcomes in eating disorder (ED) risk reduction trials are important but 32 
rarely reported.  Methods: An online pragmatic randomized-controlled trial was conducted with 33 
young-adult women in Australia and New Zealand seeking to improve their body image.  Media Smart-34 
Targeted (MS-T) was a 9-module program released weekly while control participants received tips for 35 
positive body image. Eating Disorder Examination–Questionnaire (EDE-Q) scores from baseline and 36 
12-month follow-up were used to investigate two outcomes: ED onset in those who were asymptomatic 37 
at baseline (prevention effects); and, ED remission in those who met diagnosis at baseline (treatment 38 
effects). Results: MS-T participants were 66% less likely than controls to develop an ED by 12-month 39 
follow-up (non-significant).  MS-T participants who met ED criteria at baseline were 75% less likely 40 
than controls to still meet diagnostic criteria at follow-up.  This effect was significant and remained so 41 
for both those who did and who did not access external face-to-face ED treatment during the trial.  42 
Conclusions: Whilst further investigations are necessary, MS-T has fully automated procedures, low 43 
implementation costs, the potential to be delivered at-scale to assist those assist those where face-to-44 
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Introduction 61 
Eating disorders (ED: anorexia nervosa [AN], bulimia nervosa [BN] and binge eating disorder 62 
[BED], Other Specific Feeding and Eating Disorders [OSFED]) are serious problems, characterized by 63 
high mortality (Harris & Barraclough, 1998), a destructive physical and psychological course (Johnson, 64 
Cohen, Kasen & Brook, 2002), recent increases in prevalence rates (Hay, Mond, Buttner & Darby, 65 
2008), low rates of presentation for treatment (Johnson et al., 2002), comparatively poor treatment 66 
outcomes (Steinhausen, 2002), high rates of relapse (Keel, Dorer, Franko, Jackson & Herzog, 2005), 67 
and high rates of health service use (Mond, Hay, Rodgers & Owen, 2007).  In Australia alone, 913,000 68 
people were suffering from an ED in 2012 where the estimated socioeconomic costs were $AUD69.7 69 
billion ($US52.9 billion: Butterfly Foundation, 2012). Thus while the pursuit of effective ED 70 
prevention and treatment is of critical importance, it is equally important that this be available in a 71 
manner that can be delivered at-scale to meet this overwhelming need that cannot possibly be met by 72 
traditional services.  To date, two face-to-face programs (The Body Project and Healthy Weight) have 73 
been found to reduce the onset of EDs while an online program (Student Bodies) has been found to 74 
reduce onset for sub-populations such as participants with elevated BMI at baseline (Stice, Marti, 75 
Spoor, Presnell & Shaw, 2008; Taylor et al., 2006).  76 
The purpose of this report is to examine whether Media Smart-Targeted (MS-T) can decrease 77 
EDs in young-adult women relative to a control condition. MS-T is an online adaptation of Media 78 
Smart, a school program that has been found to significantly reduce a range of ED (and obesity) risk 79 
factors in young-adolescent girls and boys (Wilksch et al., 2015; Wilksch & Wade, 2009), significantly 80 
reduce growth in girls’ shape and weight concerns over a 2.5-year follow-up (Wilksch & Wade, 2009), 81 
and halve the rate of onset of clinically-significant shape and weight concerns at 12-month follow-up 82 
(Wilksch et al., 2015).  This online intervention was not moderated, so it was different form previous 83 
targeted prevention trials shown to decrease EDs; most of the previous trials were conducted at 84 
university sites with monitoring from a therapist moderator (e.g., Taylor et al., 2006), or conducted 85 
face-to-face (Stice et al., 2008).  Whilst the school version of Media Smart is a universal program (e.g., 86 
all girls and boys in school classes included regardless of baseline levels of ED risk), MS-T was 87 
developed as a targeted (i.e., ‘indicated’) program (e.g., participants included due to elevated baseline 88 
ED risk or already reporting disordered eating behaviours).  Other targeted trials have understandably 89 
excluded those meeting ED diagnosis at baseline (Stice et al., 2008; Taylor et al., 2006), while some 90 
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have also excluded those meeting subclinical ED diagnosis or having previously accessed ED 91 
treatment (Taylor et al., 2006).     92 
A recent two-country randomized controlled trial (RCT; N=575) of MS-T focused on 93 
outcomes related to measures of continuous disordered eating (global EDE-Q score), ED risk factors, 94 
and presence/absence of disordered eating over a 12-month follow-up (Wilksch et al., 2017).  This trial 95 
was pragmatic in nature, meaning we sought to evaluate how the program would be used and its 96 
effectiveness under real-world conditions; at-scale across two countries with minimal exclusion criteria 97 
(Ford & Norrie, 2016). Individuals self-referred based on wishing to improve body image, where the 98 
only exclusion criteria were: elevated suicide risk; alcohol or substance abuse; or, self-reported BMI < 99 
15.0.  At baseline, 76% of the sample met criteria for disordered eating, defined as having a global 100 
EDE-Q score ≥ 1 SD of the community mean (i.e., M=2.46: Mond, Hay, Rodgers, Owen & Beumont, 101 
2004), in addition to a minimum of one of the following in the previous 4-weeks: fasting; vomiting; or 102 
laxatives to control weight; objective binge eating episode; or BMI <18.5.  Despite this high proportion 103 
of eating pathology, just 14.7% of the sample endorsed having received treatment in the last 12 months 104 
for ED symptoms.  As such, one of the strengths of this trial was the inclusion of many young women 105 
who were experiencing eating pathology who were not currently receiving care for these symptoms.  106 
Analyses were conducted in two ways (Wilksch et al., 2017): Intention-to-treat (ITT); and, 107 
‘measure completers’, referring to the 78% of the sample who completed who completed baseline and 108 
a minimum of one other assessment point.  ITT analyses revealed MS-T participants had significantly 109 
higher quality of life–mental relative to controls, while amongst measure completers MS-T scored 110 
significantly lower than controls on: EDE-Q global; media internalization; depressive symptoms; 111 
ineffectiveness; and, clinical impairment.  Of those with baseline DE, MS-T participants were 112 
significantly less likely than controls to still have disordered eating at 12-month follow-up.  Whilst 113 
program completion rates were low (13.6%), 41.2% (26/63) of those who completed the first module 114 
completed all modules.   115 
The aims of this research were to investigate the efficacy of MS-T with regard to clinical (or 116 
diagnostic) outcomes – namely prevention effects (outcomes for those who did not meet ED diagnosis 117 
at baseline) and treatment effects (outcomes for those who met ED diagnosis at baseline).  This 118 
responds to the calls for ED prevention scientists to give greater attention to the assessment and 119 
reporting of clinical outcomes in risk reduction trials (Becker, 2015).  120 




Full information regarding recruitment, randomization and procedures appears in a separate 123 
report (Wilksch et al., 2017).  In brief, eligible participants were young-adult women (18-25 years) 124 
seeking to improve their body image from across Australia and New Zealand.  Self-referral was used 125 
with sources including: flyers at universities (n=100; 31.9%); social media (n=87; 27.8%); and, media 126 
reports (n=60; 19.2%).  127 
Program & Procedure 128 
A full description of the 9-module MS-T program has been reported (Wilksch et al., 2017). 129 
Program content addresses prospectively identified ED risk factors (e.g., media internalization).  130 
Modules were released weekly and participants were encouraged to view interactive content, provide 131 
responses to questions, and complete homework assignments.  Whilst MS-T was developed based on 132 
Media Smart (8-lesson school version), content was changed considerably to be appropriate for a 133 
young-adult, online, female-only audience.  New content included a greater focus on social media 134 
pressures; emotion regulation; goal setting and a module to address eating-related risk factors was 135 
included (e.g., the importance of eating breakfast and regular eating).  Consistent with other targeted 136 
trials, control participants received a one-off email providing tips for positive body image (e.g., Stice et 137 
al., 2011).   138 
Procedure 139 
The study website provided participants with information, consent procedures, and baseline 140 
questionnaires.  Following questionnaire completion, the website automatically randomized 141 
participants to condition with MS-T participants were able to access their website immediately.  142 
Automated email reminders were sent to all participants to complete post-program measures 10-weeks 143 
after baseline and at 6- and 12-month follow-up. A $AUD50 gift voucher was sent to participants who 144 
completed a minimum of three waves of assessment.  Ethics approval for this research was received 145 
from the Flinders University Social and Behavioural Research Ethics Committee.   146 
Measures 147 
ED diagnosis was assessed using the Eating Disorder Examination Questionnaire (EDE-Q: 148 
see Table 1).  A systematic review concluded there was “data to support the ability of scores on the 149 
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EDE-Q to differentiate between cases and non-cases of eating disorders” (p. 436: Berg, Peterson, 150 
Frazier & Crow, 2012). The EDE-Q has been validated against the EDE interview, demonstrating 151 
moderate diagnostic concordance (Berg et al., 2012).  Whilst the interview is superior with respect to 152 
diagnosis, the EDE-Q has been used to generate diagnosis in a young-adult Australian outpatient 153 
sample (Mancuso et al., 2015) and use of the EDE-Q was well-suited to the pragmatic approach to this 154 
research. 155 
Statistical Analyses 156 
The baseline frequencies of ED cases between conditions were investigated using Chi Square 157 
analyses. Both prevention and treatment outcomes were investigated for those who completed 158 
measures at 12-month follow-up (N=205; 64.8% of baseline sample).  Odds ratios (OR) and 95% CI 159 
from logistic regressions were used to compare diagnostic status at 12-month follow-up for MS-T 160 
participants relative to controls.  These analyses were also conducted adjusting for receiving face-to-161 
face treatment (e.g., psychologist, psychiatrist) at any point in the trial.  162 
Results 163 
Participants  164 
Data that are relevant for the current report come from N=316 women (M age=20.80 years, 165 
SD=2.26). This group was comprised of all control participants (n=194) and n=122 MS-T participants 166 
(63.8%) who accessed the program at least once out of the 194 participants who were allocated to MS-167 
T.   Of this sample, a total of n=220 participants (69.6%) met criteria for ED at baseline.  The 168 
proportion of these cases was not significantly different between the MS-T (n=90; 73.8%) and control 169 
conditions (n=130; 68.1%: χ(1)=1.16, p = .281.) 170 
Prevention effects   171 
Of the participants with 12-month follow-up data, n=15 met ED criteria who did not meet ED 172 
at baseline (n=66).  Table 2 shows that MS-T participants were 66% less likely than controls to develop 173 
an ED by 12-month follow-up. Amongst those who did not seek external treatment during the trial, 174 
MS-T participants were 52% less likely than controls to meet ED diagnosis at 12-month follow-up.  175 
These results were not significant.    176 
Treatment effects  177 
Of the participants with 12-month follow-up data, n=37 participants no longer met ED criteria 178 
who did meet criteria at baseline (n=117).  Table 2 shows MS-T participants were 75% less likely than 179 
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controls to meet ED criteria at 12-month follow-up. This finding was also significant amongst both 180 
non-treatment seekers and treatment seekers, where MS-T participants were 71% and 86% less likely 181 
than their controls to meet diagnosis at 12-month follow-up.   182 
To investigate this further, logistic regressions were run separately by ED diagnoses. A significant 183 
treatment effect was found for OSFED cases (OR=0.37, 95% CI [0.14-0.98]), where MS-T participants 184 
(17/27:63.0%) were 63% less likely than controls (19/49: 38.8%) to meet diagnosis at follow-up.  This finding 185 
was also significant for those participants who did not access external face-to-face treatment during the trial 186 
cases (OR=0.32, 95% CI [0.11-0.95]).  Due to low numbers, AN, BN and BED were combined to form one 187 
omnibus outcome.  Of these cases, a higher proportion of MS-T participants (10/15: 66.6%) no longer met 188 
diagnosis at 12-month follow-up than controls (19/44: 43.2%), however this was not significant (OR=0.38, 189 
95% CI [0.11-1.30]).   190 
Discussion 191 
This trial investigated the impact of MS-T on ED diagnosis onset and remission in an online 192 
pragmatic RCT involving a community sample of self-referred young-adult women wishing to improve 193 
their body image.  Minimal exclusion criteria were used.  Two key findings emerged.  First, a treatment 194 
effect was found where MS-T significantly reduced the likelihood of continuing to meet diagnosis at 195 
12-month follow-up.  This was observed both for those who did, and did not, seek external face-to-face 196 
ED treatment.  This finding extends the original RCT report, which also found a treatment effect for 197 
participants meeting more broad disordered eating criteria (Wilksch et al., 2017). Post-hoc analyses 198 
revealed a significant effect specifically for OSFED cases, which might be related to the higher 199 
frequency of these cases compared to AN, BN and BED.  Further, whilst OSFED causes significant 200 
suffering in its own right, it is possible that MS-T prevented a proportion of these cases from 201 
‘progressing’ to one of the other diagnoses.  To achieve this without participants requiring face-to-face 202 
treatment is a promising finding that warrants further investigation.  203 
To the best of our knowlege, this was the first time a targeted program has resulted in a 204 
significant treatment effect using diagnostic outcomes.  Some previous studies have achieved 205 
reductions in disordered eating behaviours in participants with subthreshold eating disorder symptoms, 206 
but excluded those meeting full syndrome diagnoses (Jacobi, Völker, Trockel & Taylor, 2012; Saekow 207 
et al., 2015).  Whilst it is not suggested that MS-T is comparable to established ED treatment protocols, 208 
the program is well-suited to clinical samples given MS-T is online and does not include open 209 
Eating disorder diagnostic outcomes 
 8 
discussion groups.  Thus participants of varying ED risk levels can participate in MS-T without risk of 210 
causing inadvertent harm to other participants given that participant responses are not shared. 211 
Second, whilst not significant, MS-T participants were two thirds less likely than controls to 212 
become a new ED case by 12-month follow-up.  This finding is encouraging and similar to that found 213 
for face-to-face delivery of Healthy Weight (61%) and The Body Project (60%), though these findings 214 
were based on interview over a 2-3 year follow-up (Stice et al., 2008).  This lack of significance is 215 
likely due to the comparatively small proportion of participants who did not meet ED criteria at 216 
baseline. Given MS-T was originally developed as a targeted risk reduction program, it would be 217 
valuable for furture research to focus on recruiting a non-clinical sample to more fully assess MS-T’s 218 
impact as a prevention program.     219 
The limitations of this research have been previously outlined (Wilksch et al., 2017).  Of 220 
relevance to this report includes: the use of self-report rather than interview to assess ED symptoms; 221 
the 28-day time frame of EDE-Q assessment rather than the 3-month timeframe used with the EDE; 222 
and, measure completion rates being lower than other targeted prevention trials where this was 223 
exacerbated by use of online self-report assessment.  Power analyses were conducted for continuous 224 
outcomes reported in the primary RCT (Wilksch et al., 2017), thus findings for dichotomous outcomes 225 
presented need to be interpreted with caution and require replication. 226 
Whilst replication trials are required, MS-T holds promise as a program that to date has been 227 
found to: reduce ED onset by two thirds; be effective at significantly reducing eating pathology for 228 
those with baseline ED symptoms; and, which seems to augment rather than confound external 229 
treatment.  Given the low implementation costs of MS-T where it is of a ‘pure’ self-help nature with 230 
fully automated registration and access procedures, the program has potential to be delivered at-scale to 231 
assist those where face-to-face services are limited (e.g., long waiting lists), not available (e.g., remote 232 
areas), or where individuals are reluctant to attend face-to-face services.  At the population level, this is 233 
likely to be a vast number of people where currently only a fraction are receiving the help that they 234 
need.  Finally, it is of interest that while Media Smart and MS-T sit at opposite ends of the prevention 235 
spectrum (i.e., universal – targeted), both have achieved reductions in ED risk or symptoms through 236 
encouraging participants to question the validity of media (and other) messages that suggest our self-237 
worth should be primarily determined by perceptions of our appearance, shape and weight.  238 
 239 
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Table 1. 360 








AN 7 (5.7) 9 (4.7) BMI < 18.5; AND fear of gaining weight OR persistent behaviour that interferes with weight gain (fasting / vomiting / 
laxatives >4); AND at least moderate importance of shape and/or weight OR felt fat for more than half of the days (>= 4) 
BN 11 (9.0) 19 (9.8) Objective bulimic episodes (OBE) at least once per week over past 28-days; AND compensatory behaviours fasting / 
vomiting / laxatives ) at least once per week over past 28-days; AND at least moderate importance of shape and / or weight 
(>= 4); AND did not occur during an episode of AN 
BED 18 (14.8) 37 (19.2) OBE at least once per week over past 28-days; AND did not occur during an episode of other diagnosis 




Mean item EDE-Q global score >= 2.46 (i.e., global EDE-Q score ≥ 1 SD of the community mean (Mond et al., 2004) 
AND presence of one or more of the following: OBE; fasting; vomiting; laxative use; BMI< 18.5 AND did not meet 
diagnosis for AN, BN, or BED 
ED 90 (73.8) 130 (68.1) Combined total of above 4 diagnoses 
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Table 2.  369 





OR (95% CI) 
MS vs control 
Prevention effects 













2. Adjusting for treatment  













2. Adjusting for treatment  
- No treatment 











Note: a proportion per condition of new clinical eating disorder cases at 12-month follow-up: only participants who did not have ED at baseline; b proportion per condition of no 372 
longer being a clinical eating disorder case: only participants who did have ED at baseline.  Bolded values indicate significant odds ratios (p<.05). 373 
 374 
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